Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.
Currently, the educational interventions regarding the use of medicines need to be expanded and more effective, and thus set themselves up in strategies for reorganization of dispensing drugs in health services and provide support to the population to obtain greater control over their health. The pharmacist, in turn, inserted in the multidisciplinary team has an important role in health education with the aim of improving knowledge about the disease and the various treatment options, reflecting positively on treatment adherence and clinical outcomes as a result and quality of life related to patient health. Thus, health education, to share knowledge, represents an important task and involves attentive listening to the community to identify their needs and then solve them. From this perspective, therefore, the educational means to educate health and an integral formation of individuals as social actors critics who understand and question the social relations, transforming subjects into citizens participating in the process of health education, helping to raise awareness , knowledge and understanding of living conditions and relationships with health, promoting quality of life.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pharmaceutical Education | Experimental | The patients will receive pharmaceutical education. |
|
| Control | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Education interventional | Behavioral | The patients will receive pharmaceutical education to know more about asthma, the importance of treatment compliance, the medications used to control the pathology, corrected patients' inhalation techniques and the medication care. |
| Measure | Description | Time Frame |
|---|---|---|
| Knowledge of Asthma | To compare the patient´s knowledge of asthma before and after the education interventions with asthma knowledge questionnaire. | 6 months after the first evaluation |
| Measure | Description | Time Frame |
|---|---|---|
| Spirometry Exam | To compare the patient´s pulmonary function before and after the education interventions with spirometry exam. | 6 months after the first evaluation |
| Sociodemographic data, clinical and lifestyle evaluation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Osvaldo de Freitas, habilitation | Pharmaceutical Sciences Faculty of Ribeirão Preto, University of São Paolo | Study Director |
| Elcio Vianna, habilitation | Clinical Hospital of Medicine Faculty of Ribeirão Preto, University of São Paolo | Study Director |
| Carolina Olivera, Masters | Pharmaceutical Sciences Faculty of Ribeirão Preto, University of São Paolo | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinical Hospital of Medicine Faculty of Ribeirão Preto, University of São Paolo | Ribeirão Preto | São Paulo | 14048-800 | Brazil |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27473571 | Derived | Olivera CM, Vianna EO, Bonizio RC, de Menezes MB, Ferraz E, Cetlin AA, Valdevite LM, Almeida GA, Araujo AS, Simoneti CS, de Freitas A, Lizzi EA, Borges MC, de Freitas O. Asthma self-management model: randomized controlled trial. Health Educ Res. 2016 Oct;31(5):639-52. doi: 10.1093/her/cyw035. Epub 2016 Jul 29. |
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 8, 2023 | |
| Reset | Jan 26, 2024 | |
| Release | Feb 1, 2024 | |
| Reset | Jul 18, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 8, 2023 | Jan 26, 2024 | |||
| Feb 1, 2024 |
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010593 | Pharmaceutical Services |
| ID | Term |
|---|---|
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
To evaluate the sociodemographic data, clinical and lifestyle before and after the education interventions and its impact on the quality of life.
| 6 months after the first evaluation |
| Management of inhalers | To evaluate the technique for using inhalation devices among asthma patients before and after education interventions. Patients will be asked to demonstrate their inhaler technique. | 6 months after the first evaluation |
| Treatment compliance evaluation | To evaluate the treatment compliance with Morisky&Green test and pharmacy database query before and after educations interventions. | 6 months after the first evaluation |
| Economic analysis | Economic analysis after the model implementation. | 6 months after the first evaluation |
| Quality of Life Evaluation | To compare the Quality of Life before and after the education interventions | 6 months after the first evaluation |
| Jul 18, 2024 |
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |